Paper228940
Establishment and characterization of a cell line of human breast carcinoma origin.
Keydar I and 7 others. Eur J Cancer (1965), 1979. Cited by 655 papers, by iCite.
Cite this record
ConductScience Library. Establishment and characterization of a cell line of human breast carcinoma origin. Papers, record 228940. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/228940
- Cell line
- T-47D290 papers
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Connected records1
Records in the library's other databases whose lists name this one, each read from that database's own release: up to 20 of each kind, the most connected first.
Cell lines1
Source Cell lines
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Breast Neoplasms | Major topic |
| Carcinoma, Intraductal, Noninfiltrating | Major topic |
| Cell Line | Major topic |
| Caseins | |
| Estradiol | |
| Female | |
| Fluorescent Antibody Technique | |
| Humans | |
| Karyotyping | |
| Microscopy, Electron | |
| Middle Aged | |
| Pleural Effusion | |
| Receptors, Androgen | |
| Receptors, Estrogen | |
| Receptors, Glucocorticoid | |
| Receptors, Progesterone |
Source PubMed
Cited by186
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 655 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42501117 | Dual modulation of intracellular Ca2+ signaling by hispidulin through endoplasmic reticulum mobilization and extracellular Ca2+ entry in human breast cancer cells. | J Mol Histol | 2026 | https://conductscience.org/library/papers/42501117 | PubMed |
| 41336283 | Translocation of benzo(a)pyrene reactive metabolites across human mammary epithelial cell membranes. | PLoS One | 2025 | https://conductscience.org/library/papers/41336283 | PubMed |
| 41111912 | Multilevel classification framework for breast cancer cell selection and its integration with advanced disease models. | iScience | 2025 | https://conductscience.org/library/papers/41111912 | PubMed |
| 40910266 | Insights on the differences between two‑ and three‑dimensional culture systems in tumor models (Review). | Int J Mol Med | 2025 | https://conductscience.org/library/papers/40910266 | PubMed |
| 39452867 | Marine Staurosporine Analogues: Activity and Target Identification in Triple-Negative Breast Cancer. | Mar Drugs | 2024 | https://conductscience.org/library/papers/39452867 | PubMed |
| 39060878 | Failure to progress: breast and prostate cancer cell lines in developing targeted therapies. | Cancer Metastasis Rev | 2024 | https://conductscience.org/library/papers/39060878 | PubMed |
| 38486205 | Role of beta-(1→3)(1→6)-D-glucan derived from yeast on natural killer (NK) cells and breast cancer cell lines in 2D and 3D cultures. | BMC Cancer | 2024 | https://conductscience.org/library/papers/38486205 | PubMed |
| 38408073 | Nutraceuticals known to promote hair growth do not interfere with the inhibitory action of tamoxifen in MCF7, T47D and BT483 breast cancer cell lines. | PLoS One | 2024 | https://conductscience.org/library/papers/38408073 | PubMed |
| 38391914 | Molecular Characterization and Subtyping of Breast Cancer Cell Lines Provide Novel Insights into Cancer Relevant Genes. | Cells | 2024 | https://conductscience.org/library/papers/38391914 | PubMed |
| 38172946 | Predictive, preventive, and personalized medicine in breast cancer: targeting the PI3K pathway. | J Transl Med | 2024 | https://conductscience.org/library/papers/38172946 | PubMed |
| 37111093 | Comparison of Three Low-Molecular-Weight Fluorescent Probes for Measuring Free Zinc Levels in Cultured Mammary Cells. | Nutrients | 2023 | https://conductscience.org/library/papers/37111093 | PubMed |
| 36992834 | Cyclopia extracts act as selective estrogen receptor subtype downregulators in estrogen receptor positive breast cancer cell lines: Comparison to standard of care breast cancer endocrine therapies and a selective estrogen receptor agonist and antagonist. | Front Pharmacol | 2023 | https://conductscience.org/library/papers/36992834 | PubMed |
| 36893152 | Effects of β-caryophyllene and oxygen availability on cholesterol and fatty acids in breast cancer cells. | PLoS One | 2023 | https://conductscience.org/library/papers/36893152 | PubMed |
| 36727068 | Invasiveness of endometrial cancer cell lines is potentiated by estradiol and blocked by a traditional medicine Guizhi Fuling at clinically relevant doses. | Front Oncol | 2022 | https://conductscience.org/library/papers/36727068 | PubMed |
| 36600151 | The genomic regulation of metastatic dormancy. | Cancer Metastasis Rev | 2023 | https://conductscience.org/library/papers/36600151 | PubMed |
| 35897723 | Low-Dose-Rate Radiation-Induced Secretion of TGF-β3 Together with an Activator in Small Extracellular Vesicles Modifies Low-Dose Hyper-Radiosensitivity through ALK1 Binding. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35897723 | PubMed |
| 35668111 | Estrogen receptor positive breast cancers have patient specific hormone sensitivities and rely on progesterone receptor. | Nat Commun | 2022 | https://conductscience.org/library/papers/35668111 | PubMed |
| 35205789 | Tumor Cell-Autonomous Pro-Metastatic Activities of PD-L1 in Human Breast Cancer Are Mediated by PD-L1-S283 and Chemokine Axes. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/35205789 | PubMed |
| 34680281 | Enhanced IFNα Signaling Promotes Ligand-Independent Activation of ERα to Promote Aromatase Inhibitor Resistance in Breast Cancer. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/34680281 | PubMed |
| 34680243 | [99mTc]Tc-DB15 in GRPR-Targeted Tumor Imaging with SPECT: From Preclinical Evaluation to the First Clinical Outcomes. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/34680243 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/228940
GET https://conductscience.org/api/papers/v1/228940/cited_by?page=2